https://www.lomondther.com/news daily 0.75 2025-06-20 https://www.lomondther.com/news/lomond-therapeutics-announces-us-fda-clearance-of-ind-application-for-lonitoclax monthly 0.5 2025-06-20 https://www.lomondther.com/news/lomond-therapeutics-completes-second-and-third-closings-and-adds-two-new-investors monthly 0.5 2025-04-03 https://www.lomondther.com/news/lomond-therapeutics-reports-results-from-ongoing-clinical-studies-of-lonitoclax-a-selective-bcl-2-inhibitor-with-best-in-class-selectivity-versus-bcl-xl-and-no-cyp-3a4-liability monthly 0.5 2025-07-02 https://www.lomondther.com/news/lomond-therapeutics-announces-upcoming-presentation-at-the-ash-annual-meeting monthly 0.5 2025-07-02 https://www.lomondther.com/news/lomond-therapeutics-completes-reverse-merger-and-closes-44-million-private-placement monthly 0.5 2025-07-02 https://www.lomondther.com/news/lomond-therapeutics-announces-fda-clearance-of-ind-application-for-phase-1-study-of-lonitoclax monthly 0.5 2025-07-02 https://www.lomondther.com/news/category/press+releases monthly 0.5 https://www.lomondther.com/publications-1 daily 0.75 2024-10-16 https://www.lomondther.com/publications-1/a-novel-selective-bcl2-inhibitor-with-limited-immune-suppression-and-improved-safety-compared-to-venetoclax-g2bnt monthly 0.5 2025-07-02 https://www.lomondther.com/publications-1/therapeutic-targeting-of-flt3-gate-keeper-mutation-with-e2082-0047-in-traditional-and-a-novel-immunocompetent-murine-adoptive-transfer-model-of-aml-npbhy monthly 0.5 2025-07-02 https://www.lomondther.com/publications-1/ash2022-a-novel-inhibitor-of-flt3-and-its-drug-resistant-mutants-with-superior-activity-to-gilteritinib-in-molm-13-preclinical-acute-myeloid-leukemia-xenograft-model-rg7gs monthly 0.5 2025-07-02 https://www.lomondther.com/about daily 0.75 2024-11-11 https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110206769-WZ0GWYWLLBEZX7YEB4S6/2+%287%29.png https://www.lomondther.com/approach daily 0.75 2024-10-28 https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110208580-D0DHTA6JOFQP4YBNCVAV/3+%287%29.png https://www.lomondther.com/ze46-0134 daily 0.75 2024-10-16 https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110209556-Y4ZTT9S7D0Z1TVS22MTR/2+%287%29.png https://www.lomondther.com/contact daily 0.75 2025-01-10 https://www.lomondther.com/pipeline daily 0.75 2025-12-22 https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110212524-JQ6XXPIJV8YSPNNYFRH3/graph+eileanArtboard+1.png https://www.lomondther.com/board-of-directors daily 0.75 2024-10-29 https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110213614-JE5MM06N6FB0TDTK0P7K/Untitled+design+%286%29.png Board of Directors https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110213620-9MSWOIWPUSSEWE2GHTDC/3.png Board of Directors https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110213624-5ULFY0XSK5ULGMR6AMGU/Untitled+design+%2880%29.png Board of Directors https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110213627-LNH04VTX9BYPZC66ZZK5/10+%283%29.png Board of Directors https://www.lomondther.com/ze50-0134 daily 0.75 2024-10-16 https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110214562-FFAW1VAK0R3EV3U0JJLO/2+%287%29.png https://www.lomondther.com/ze63-302 daily 0.75 2024-10-16 https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110215534-JQ9B0RTDHOOB4JZ5RCX3/2+%287%29.png https://www.lomondther.com/management-team daily 0.75 2025-03-14 https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110217652-B2J88H8CKVUTEEWHWUF1/Untitled+design+%286%29.png Management Team https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110217659-RCCRL6WRLANGBF524NG9/Untitled+design+%2879%29.png Management Team https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110217662-704OVTK4IDYYSOUQW1M1/Untitled+design+%287%29.png Management Team https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110217666-33O9WPOAYQ4DL5L4Q3AM/6+%286%29.png Management Team https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110217669-INI3HIRUU1PUZ5S0BVBU/7+%285%29.png Management Team https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110217673-KO7QM4F0NKB73LPYIAYD/Untitled+design+%285%29.png Management Team https://www.lomondther.com/home daily 1.0 2024-12-30 https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1733762026789-QC6NV490ZPUM0T81HOQQ/unsplash-image-NbZQYileaOI.jpg https://www.lomondther.com/sab daily 0.75 2024-12-04 https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110221896-O6X2I36O29FGO5CQ118I/8+%283%29.png Scientific Advisory Board https://images.squarespace-cdn.com/content/v1/671020bdf537a4557ea1694d/1729110221900-SXSJ4PP7U0T8XQGL7QYP/11+%282%29.png Scientific Advisory Board